About us

Our character

Cortex Health, is a locally based distributor of highly specialised medical products and medical foods. Our background is in medical research, patient support initiatives and commercialisation within the local environment for the Australian & NZ community.

Since 2013, Cortex was the first company in Australia to introduce glycomarcopeptide (GMP) for PKU which has now become synonymous with high quality formula for children (1+) and adults alike. Now our product ranges has expanded and dedicated to those with rare or complex conditions that can derive clinical benefit from some of the most advanced medical formula available worldwide. Our intent is to be a partner to the clinicians who manage these conditions and provide the highest level of support/service to patients and carers

At present, our range includes world-leading formula for phenylketonuria (PKU), tyrosinaemia (TYR), Ketogenic Diet Therapy and Severe Protein Allergy. These are sourced from expert companies in the USA and Japan. Our partner & supplier in the USA, Cambrooke Therapeutics, part of the Ajinomoto group of companies, share of passion to develop & provide unique medical formulae.

Our philosophy is simple… Focus on the Patient, Focus on the Medicine


Our goal is to do what’s right for any of these patients and add value where we can.

Our Mission & aim

Our Mission is to provide access to products that were previously out of reach for many Australians & New Zealanders and to be a partner to the clinics which manage them.

We aim to provide world-leading formula

Our Commitment

We promise to make available through PBS and reimbursed channels our range of PKU, TYR, Ketogenic and Severe protein allergy products and support the clinics & patients. We acknowledge our responsibility for continued supply and dedicate ourselves to bring new formula to the Australian & NZ patients.

Our advisory board

Cortex Health is very fortunate to have advice from and counsel with a highly experienced group of experts.

Dr David Tognarini
Dr Sherif Youssef

Our exceptional team

We are a team of dedicated and passionate professionals ready to help when you need it

Andrea Traficante
Dietician
Nicole Ott
Support
Jo-Anne Watt
Finance

Find your balance

Our goal is to do what’s right for any of our patients and add value where we can.

Are you a healthcare professional?

If you are a healthcare professional, and would like more detailed information about our products, wish to discuss a patient case or request samples of the formula, please contact us.

You can send your enquiry by completing this section with as much detail as possible & it will be sent to appropriate division within Cortex Health.

We aim to respond within 1-2 business days. If your matter is urgent, please call us on the 1800 367 758 or email us on info@cortexhealth.com.au 

Send us a message
X
Mr Joe Baini

Mr Joe Baini is one of Australia’s leading pharmaceutical & biotechnology executives with over  30 years experience.  Past positions have included Aust/NZ General Manager of within global organisations (Gilead Sciences), Interim CEOs for ASX listed companies (Immuron Limited) & start-up companies (PresSura Neuro Ltd) as well as holding Director positions for ASX listed entities (Avexa & Bluechiip).  Achievements have included growing a multi national pharma company by 900% & orchestrating a complete change in direction to take a company away from closure into growth, development & positive revenue.

Joe has extensive experience on commercialisation, government relations, licensing negotiations, strategic management of IP as well as actively involved in capital raising.  In his spare time, he has mentored others in senior positions across the Industry thus helping forge an ethos of delivering and instilling the ethics of partnership and accountability.

Joe is a founding member of the Cortex Advisory Board and brings this wealth of experience to the small but dedicated team.

Mr Richard Bowen

A driven, accomplished and authentic business leader with over 20 years of C-level management experience, Richard is a consultant to number of businesses in the health and med-tech sectors. Starting his career as a lawyer Richard moved into operations management, then led significant transformation projects in health, financial services, logistics, IT and retail. He was a Director of Health Purchasing Victoria and Non-Clinical Co-Chair of the Global GS1 Healthcare Providers Advisory Panel. Working with a range of businesses – from start-ups to community to government to large corporates – Richard’s passion is bringing great ideas to life. 

Richard holds Bachelors of Law and Commerce from the University of Melbourne, and a Graduate Diploma in Transport & Distribution Management from RMIT. He is a Graduate of the Australian Institute of Company Directors. He is also the Chairperson of the South Metro Junior Football League, the largest Australian Rules football league in Australia. 

Dr Warwick Tong
Warwick Tong MB ChB MPP GAICD

Warwick is a NZ trained physician with more than 28 years’ experience in the Pharmaceutical and Biotechnology industry. After his early career in General Medical Practice Warwick has held a wide variety of roles in the pharmaceutical and biotech industry in NZ(Glaxo) Singapore (GlaxoWellcome) London (GSK), Boston (Surface Logix) and Melbourne (CTx – Cancer Therapeutics CRC). His roles have included; Medical Director, Regional Business Development Director (Asia Pacific), Commercial Strategy Director (International) and SVP Development (USA).

Currently he is a director and Chair of Amplia Therapeutics (ASX:ATX), a director of CannaPacific Pty Ltd and its affiliate e3DPharma and a director of Aculeus Therapeutics Pty Ltd. He was CEO and Director of CTx from 2011 until April 2018. He is a member of the SAB of the Maurice Wilkins Centre in Auckland NZ, the Advisory Board of Cortex Health, Melbourne, and a member of the CSIRO Manufacturing, Business Advisory Committee.

Warwick was educated at the University of Auckland and Victoria University, Wellington, New Zealand and is a Graduate of the Australian Institute of Company Directors.